381 related articles for article (PubMed ID: 31658757)
1. Predicting Gonadal Germ Cell Cancer in People with Disorders of Sex Development; Insights from Developmental Biology.
Looijenga LHJ; Kao CS; Idrees MT
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31658757
[TBL] [Abstract][Full Text] [Related]
2. Gonadoblastoma Y locus genes expressed in germ cells of individuals with dysgenetic gonads and a Y chromosome in their karyotypes include DDX3Y and TSPY.
Vogt PH; Besikoglu B; Bettendorf M; Frank-Herrmann P; Zimmer J; Bender U; Knauer-Fischer S; Choukair D; Sinn P; Lau YC; Heidemann PH; Strowitzki T
Hum Reprod; 2019 Apr; 34(4):770-779. PubMed ID: 30753444
[TBL] [Abstract][Full Text] [Related]
3. Tumor risk in disorders of sex development (DSD).
Looijenga LH; Hersmus R; Oosterhuis JW; Cools M; Drop SL; Wolffenbuttel KP
Best Pract Res Clin Endocrinol Metab; 2007 Sep; 21(3):480-95. PubMed ID: 17875493
[TBL] [Abstract][Full Text] [Related]
4. The biology of germ cell tumors in disorders of sex development.
Hersmus R; van Bever Y; Wolffenbuttel KP; Biermann K; Cools M; Looijenga LH
Clin Genet; 2017 Feb; 91(2):292-301. PubMed ID: 27716895
[TBL] [Abstract][Full Text] [Related]
5. New insights into type II germ cell tumor pathogenesis based on studies of patients with various forms of disorders of sex development (DSD).
Hersmus R; de Leeuw BH; Wolffenbuttel KP; Drop SL; Oosterhuis JW; Cools M; Looijenga LH
Mol Cell Endocrinol; 2008 Sep; 291(1-2):1-10. PubMed ID: 18403106
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of germ cell neoplasia in testicular dysgenesis and disorders of sex development.
Jørgensen A; Lindhardt Johansen M; Juul A; Skakkebaek NE; Main KM; Rajpert-De Meyts E
Semin Cell Dev Biol; 2015 Sep; 45():124-37. PubMed ID: 26410164
[TBL] [Abstract][Full Text] [Related]
7. Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY.
Kersemaekers AM; Honecker F; Stoop H; Cools M; Molier M; Wolffenbuttel K; Bokemeyer C; Li Y; Lau YF; Oosterhuis JW; Looijenga LH
Hum Pathol; 2005 May; 36(5):512-21. PubMed ID: 15948118
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of c-KIT mutations in gonadoblastoma and dysgerminomas of patients with disorders of sex development (DSD) and ovarian dysgerminomas.
Hersmus R; Stoop H; van de Geijn GJ; Eini R; Biermann K; Oosterhuis JW; Dhooge C; Schneider DT; Meijssen IC; Dinjens WN; Dubbink HJ; Drop SL; Looijenga LH
PLoS One; 2012; 7(8):e43952. PubMed ID: 22937135
[TBL] [Abstract][Full Text] [Related]
9. Gonadal maldevelopment as risk factor for germ cell cancer: towards a clinical decision model.
van der Zwan YG; Biermann K; Wolffenbuttel KP; Cools M; Looijenga LH
Eur Urol; 2015 Apr; 67(4):692-701. PubMed ID: 25240975
[TBL] [Abstract][Full Text] [Related]
10. Gonadoblastoma: origin and outcome.
Roth LM; Cheng L
Hum Pathol; 2020 Jun; 100():47-53. PubMed ID: 31805291
[TBL] [Abstract][Full Text] [Related]
11. Gonadoblastoma arising in undifferentiated gonadal tissue within dysgenetic gonads.
Cools M; Stoop H; Kersemaekers AM; Drop SL; Wolffenbuttel KP; Bourguignon JP; Slowikowska-Hilczer J; Kula K; Faradz SM; Oosterhuis JW; Looijenga LH
J Clin Endocrinol Metab; 2006 Jun; 91(6):2404-13. PubMed ID: 16608895
[TBL] [Abstract][Full Text] [Related]
12. Ovarian dysgerminomas are characterised by frequent KIT mutations and abundant expression of pluripotency markers.
Hoei-Hansen CE; Kraggerud SM; Abeler VM; Kaern J; Rajpert-De Meyts E; Lothe RA
Mol Cancer; 2007 Feb; 6():12. PubMed ID: 17274819
[TBL] [Abstract][Full Text] [Related]
13. Neoplastic potential of germ cells in relation to disturbances of gonadal organogenesis and changes in karyotype.
Słowikowska-Hilczer J; Romer TE; Kula K
J Androl; 2003; 24(2):270-8. PubMed ID: 12634315
[TBL] [Abstract][Full Text] [Related]
14. The Y-encoded TSPY protein: a significant marker potentially plays a role in the pathogenesis of testicular germ cell tumors.
Li Y; Tabatabai ZL; Lee TL; Hatakeyama S; Ohyama C; Chan WY; Looijenga LH; Lau YF
Hum Pathol; 2007 Oct; 38(10):1470-81. PubMed ID: 17521702
[TBL] [Abstract][Full Text] [Related]
15. Testis-specific protein Y-encoded gene is expressed in early and late stages of gonadoblastoma and testicular carcinoma in situ.
Li Y; Vilain E; Conte F; Rajpert-De Meyts E; Lau YF
Urol Oncol; 2007; 25(2):141-6. PubMed ID: 17349529
[TBL] [Abstract][Full Text] [Related]
16. Tumor risk in disorders of sex development.
Pleskacova J; Hersmus R; Oosterhuis JW; Setyawati BA; Faradz SM; Cools M; Wolffenbuttel KP; Lebl J; Drop SL; Looijenga LH
Sex Dev; 2010 Sep; 4(4-5):259-69. PubMed ID: 20558977
[TBL] [Abstract][Full Text] [Related]
17. Gonadal malignancy in 13 consecutive collected patients with disorders of sex development (DSD) from Semarang (Indonesia).
Juniarto AZ; Setyawati BA; Miranti IP; Santosa A; Hersmus R; Stoop H; Cools M; Oosterhuis JW; Drop SL; Faradz SM; Looijenga LH
J Clin Pathol; 2013 Mar; 66(3):198-204. PubMed ID: 23268320
[TBL] [Abstract][Full Text] [Related]
18. Dissecting the molecular pathways of (testicular) germ cell tumour pathogenesis; from initiation to treatment-resistance.
Looijenga LH; Gillis AJ; Stoop H; Biermann K; Oosterhuis JW
Int J Androl; 2011 Aug; 34(4 Pt 2):e234-51. PubMed ID: 21564133
[TBL] [Abstract][Full Text] [Related]
19. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
20. The risk of neoplasm associated with dysgenetic testes in prepubertal and pubertal/adult patients.
Slowikowska-Hilczer J; Szarras-Czapnik M; Wolski JK; Oszukowska E; Hilczer M; Jakubowski L; Walczak-Jedrzejowska R; Marchlewska K; Filipiak E; Kaluzewski B; Baka-Ostrowska M; Niedzielski J; Kula K
Folia Histochem Cytobiol; 2015; 53(3):218-26. PubMed ID: 26314751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
